Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Kras'

Kras published presentations and documents on DocSlides.

Targeting KRAS G12C  in Solid Tumors
Targeting KRAS G12C  in Solid Tumors
by morton
: . A . New Anticancer Approach  . Marwan Fakih, ...
Targeting KRAS and down streaming
Targeting KRAS and down streaming
by alexa-scheidler
pathways. Federico Cappuzzo. Istituto Toscano Tum...
Clinical interpretation of genomic variants
Clinical interpretation of genomic variants
by trinity
Harriet Feilotter, PhD, FCCMG, FACMG. Professor, D...
2597 REKA-TIMAVO FLOW SYSTEM IN KRAS/CARSO
2597 REKA-TIMAVO FLOW SYSTEM IN KRAS/CARSO
by easyho
Seminar 2: . wednesday. . JuLY. 31, 2019. (LEARN...
Demonstrating Clinical Effectiveness of a Follow-On Companion Diagnostic Test When a New Clinical
Demonstrating Clinical Effectiveness of a Follow-On Companion Diagnostic Test When a New Clinical
by yoshiko-marsland
Abha. Sharma, Roche Molecular . Systems, May 201...
Molecular Subtypes:
Molecular Subtypes:
by giovanna-bartolotta
Not Quite Ready . for Prime Time. Scott Kopetz, M...
Carcinosi peritoneale sincrona da carcinoma colorettale: ci
Carcinosi peritoneale sincrona da carcinoma colorettale: ci
by calandra-battersby
Quale chemioterapia sistemica?. Dott. Giuseppe Co...
MEK Inhibitors and their potential role in relapsed NSCLC
MEK Inhibitors and their potential role in relapsed NSCLC
by debby-jeon
Ranee Mehra, MD. Fox Chase Cancer Center. Philade...
Department of GI Medical Oncology
Department of GI Medical Oncology
by danika-pritchard
Does . the New EPOC trial . eliminate. . Anti. -...
SW GLH services for NSCLC – An update
SW GLH services for NSCLC – An update
by everly
Professor Rachel Butler. The genomic complexity of...
Figure S1 . Effect of avutometinib on cell viability of NCI-H358 cells.
Figure S1 . Effect of avutometinib on cell viability of NCI-H358 cells.
by amelia
The NCI-H358 cells were treated with avutometinib ...
A better clinical pathway for cancer monitoring
A better clinical pathway for cancer monitoring
by BlessedBeyondMeasure
Antonius Schuh, Ph.D. | . Chief Executive Office...
2SCIENTIFIC REPO 2020 109162 wvwvyzwvxvvz
2SCIENTIFIC REPO 2020 109162 wvwvyzwvxvvz
by stella
dysregulated KRAS-RalB-NF-B is pathway was reporte...
Josep Tabernero, MD PhD Medical Oncology Department Vall
Josep Tabernero, MD PhD Medical Oncology Department Vall
by test
Josep Tabernero, MD PhD Medical Oncology Depa...
Challenges in RAS Wild-Type mCRC
Challenges in RAS Wild-Type mCRC
by marina-yarberry
Introduction. Decision-Making Algorithm for First...
Of mice and men – Development of a mouse model for intrahepatic cholangiocarcinoma
Of mice and men – Development of a mouse model for intrahepatic cholangiocarcinoma
by alexa-scheidler
Targeting BAP1 mutations in intrahepatic . cholan...
No Does the New EPOC trial eliminate anti-EGFR antibodies a
No Does the New EPOC trial eliminate anti-EGFR antibodies a
by sherrill-nordquist
The New EPOC Study. Randomi. ze. Surgery. Oxalipl...
Clinical Considerations in the Management of Metastatic Col
Clinical Considerations in the Management of Metastatic Col
by danika-pritchard
Disease Progression. Program Goals. Introduction....
Dominika Kras
Dominika Kras
by alexa-scheidler
Sicily. Sicily is the largest island of the Medit...